FDA Approves Brytly, a New Nonprescription Eye Drop for Relief of Eye Redness

The U.S. Food and Drug Administration (FDA) has approved Brytly (apraclonidine ophthalmic solution, 0.125%) as a new nonprescription eye drop for the temporary relief of eye redness due to minor irritations. This marks the first nonprescription eye drop containing apraclonidine, expanding consumer access to safe and effective treatments for this common condition.